Morpholino

MO2-ap1g1

ID
ZDB-MRPHLNO-170808-5
Name
MO2-ap1g1
Previous Names
None
Target
Sequence
5' - AAGTCACTGCAGAGAGAAGAAACGT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-ap1g1
Expressed Gene Anatomy Figures
lef1 Fig. 6 from Zizioli et al., 2017
neurod1 Fig. 6 from Zizioli et al., 2017
neurog1 Fig. 6 from Zizioli et al., 2017
pax2a Fig. 6 from Zizioli et al., 2017
Phenotype
Phenotype resulting from MO2-ap1g1
Phenotype Fish Figures
artery malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
blood cell mislocalised, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
blood circulation decreased occurrence, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
blood vessel lumenization decreased occurrence, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
caudal fin curved, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
caudal fin kinked, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
diencephalon neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
dorsal longitudinal anastomotic vessel malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
forebrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
forebrain morphology, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
fourth ventricle absent, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
fourth ventricle lef1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
head morphology, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
heart edematous, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
hindbrain neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
hindbrain pax2a expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
hindbrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
hindbrain morphology, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
intersegmental vessel malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
midbrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
midbrain morphology, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary lef1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary pax2a expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
somite shape, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
spinal cord neuron neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
tegmentum neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
telencephalon lef1 expression decreased amount, abnormal WT + MO2-ap1g1 Fig. 6 from Zizioli et al., 2017
trunk decreased thickness, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
vein malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 Fig. 7 from Zizioli et al., 2017
ventral fin fold absent, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
ventral fin fold decreased size, abnormal WT + MO2-ap1g1 Fig. 5 from Zizioli et al., 2017
Phenotype of all Fish created by or utilizing MO2-ap1g1
Phenotype Fish Conditions Figures
fourth ventricle lef1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
telencephalon lef1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
ventral fin fold decreased size, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain hindbrain boundary neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
midbrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
caudal fin kinked, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
caudal fin curved, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
tegmentum neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
fourth ventricle absent, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
hindbrain pax2a expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
diencephalon neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
forebrain morphology, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
head morphology, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain hindbrain boundary lef1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
hindbrain morphology, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary pax2a expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
forebrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
spinal cord neuron neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
somite shape, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
heart edematous, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
hindbrain neurod1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
ventral fin fold absent, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain morphology, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
trunk decreased thickness, abnormal WT + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
hindbrain neurog1 expression decreased amount, abnormal WT + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
blood cell mislocalised, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
intersegmental vessel malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
dorsal longitudinal anastomotic vessel malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
blood circulation decreased occurrence, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
artery malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
vein malformed, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
blood vessel lumenization decreased occurrence, abnormal sd2Tg; y1Tg + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
telencephalon lef1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
fourth ventricle lef1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary neurod1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
caudal fin kinked, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain neurod1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
ventral fin fold decreased size, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
caudal fin curved, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
tegmentum neurog1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
fourth ventricle absent, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
hindbrain pax2a expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
diencephalon neurog1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
forebrain morphology, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
head morphology, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain hindbrain boundary lef1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
whole organism decreased life span, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
notochord axis elongation decreased occurrence, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 8 from Zizioli et al., 2017
hindbrain morphology, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
forebrain neurod1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
midbrain hindbrain boundary pax2a expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
spinal cord neuron neurog1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
heart edematous, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
somite shape, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
hindbrain neurod1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
ventral fin fold absent, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
trunk decreased thickness, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 5 from Zizioli et al., 2017
midbrain morphology, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
hindbrain neurog1 expression decreased amount, abnormal WT + MO1-ap1g2 + MO2-ap1g1 control Fig. 6 from Zizioli et al., 2017
trunk EGFP expression decreased amount, abnormal mw29Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 8 from Zizioli et al., 2017
BMP signaling pathway decreased occurrence, abnormal mw29Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 8 from Zizioli et al., 2017
blood cell mislocalised, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
intersegmental vessel malformed, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
dorsal longitudinal anastomotic vessel malformed, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
blood circulation decreased occurrence, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
artery malformed, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
vein malformed, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
blood vessel lumenization decreased occurrence, abnormal sd2Tg; y1Tg + MO1-ap1g2 + MO2-ap1g1 control Fig. 7 from Zizioli et al., 2017
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.